SEC Form 4 · accession 0001354488-15-003977
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas Drysdale
Officer — Chief Executive Officer · Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 19, 2015 · 11:45 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 18, 2015 | P | 8,500 | $4.689 | A | 95,161 | D |
Table II — derivative securities
No Table II lines on this filing.